4 Largecap Fund Backed Fast Profit Growth Stocks to Watch for Future Multibagger Potential: M&M, CG Power, Apollo Hospitals and Laurus Labs
- October 30, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
M&M Rs 2,890. CG Power Rs 829.80. Apollo Hospitals Rs 8,200. Laurus Labs Rs 2,244. Market caps from Rs 1.18 lakh crore to Rs 3.51 lakh crore. Data as of 29 Oct 2026.
Quick Answer
M&M, CG Power, Apollo Hospitals and Laurus Labs are the 4 picks in this fund backed fast profit growth stocks watchlist, with market caps between Rs 1.18 lakh crore and Rs 3.51 lakh crore. M&M stands out for the fastest profit growth, 26.58% a year since FY22, while CG Power offers the biggest five-year price gain at 563.19%. PE ratios run from 17.35 to 108.57, so compare each one with its industry PE before investing. All figures are as of 29 October 2026.
Fund backed fast profit growth stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. M&M, CG Power, Apollo Hospitals and Laurus Labs meet that test, with market caps from Rs 1.18 lakh crore to Rs 3.51 lakh crore and M&M offering the fastest profit growth, 26.58% a year since FY22. Each of these companies has a combined FII and DII holding of at least 30 per cent and FY26 net profit growth of at least 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a combined FII and DII holding of at least 30 per cent and FY26 net profit growth of at least 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening fund backed fast profit growth stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 29 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Fund Backed Fast Profit Growth Stocks and Why Do They Attract Multibagger Interest?
Fund backed fast profit growth stocks are shares of large companies in which foreign and domestic funds together own at least three tenths of the business and profit grew by twenty per cent or more in FY26. The four here cover utility vehicles, hospitals, pharmaceutical ingredients and electrical equipment.
Large funds study businesses in depth before they invest, so a big institutional stake together with fast profit growth shows that professional money backs the growth story. For fund backed fast profit growth stocks, both FY26 and the latest quarter showed growth. Whichever way you read fund backed fast profit growth stocks, the common thread is rising profit backed by complete financial data. For fund backed fast profit growth stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of fund backed fast profit growth stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for fund backed fast profit growth stocks before you decide.
Fund Backed Fast Profit Growth Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 29 October 2026. M&M has the lowest PE of the group at 17.35, while Apollo Hospitals posts the highest return on equity at 20.48%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Mahindra & Mahindra | 2,890 | 3,51,212 | 17.35 | 23.82 | 18.37% | 1.44 | 2,744.30 to 3,839.90 |
| CG Power and Industrial Solutions | 829.80 | 1,30,876 | 105.56 | 45.89 | 15.13% | 0.01 | 525.50 to 980.90 |
| Apollo Hospitals Enterprise | 8,200 | 1,23,036 | 56.64 | 60.75 | 20.48% | 0.90 | 6,696.50 to 9,070.50 |
| Laurus Labs | 2,244 | 1,18,375 | 108.57 | 36.42 | 16.77% | 0.48 | 864.70 to 2,244.00 |
M&M: 26.58% Profit CAGR Since FY22
Mahindra & Mahindra is one of the largest SUV makers in India and the country’s largest tractor maker, with financial services and electric vehicles in its portfolio. It reported FY26 revenue of Rs 2,02,084.34 crore, up 25.21% year on year, and net profit of Rs 18,621.71 crore, up 32.32%. Net profit has compounded at 26.58% a year since FY22, while revenue has grown 22.04% a year. Operating margin was 21.19% in FY26.
In the June 2026 quarter, revenue rose 27.47% to Rs 59,203.60 crore and net profit grew 37.04% to Rs 5,997.56 crore. The share price has gained 220.52% over five years. Domestic institutions raised their holding from 29.59% in June 2025 to 32.65% in June 2026. The stock trades at a PE of 17.35 against an industry PE of 23.82, below the sector average, with a return on equity of 18.37%.
CG Power: Revenue Up 25.73% in FY26
CG Power and Industrial Solutions makes transformers, motors, drives and railway signalling products, and has entered semiconductor assembly. It reported FY26 revenue of Rs 12,662.22 crore, up 25.73% year on year, and net profit of Rs 1,196.73 crore, up 23.00%. Net profit has compounded at 17.42% a year since FY22, while revenue has grown 23.06% a year. Operating margin was 14.88% in FY26. The debt-to-equity ratio is 0.01, which keeps interest costs low.
The stock trades at a PE of 105.56 against an industry PE of 45.89, with a return on equity of 15.13%. In the June 2026 quarter, revenue rose 15.76% to Rs 3,364.39 crore and net profit grew 15.52% to Rs 308.28 crore. The share price has gained 563.19% over five years. Domestic institutions raised their holding from 16.33% in July 2025 to 18.30% in June 2026.
Apollo Hospitals: Return on Equity of 20.48%
Apollo Hospitals Enterprise runs one of India’s largest hospital networks and also operates pharmacies and a digital health platform. It reported FY26 revenue of Rs 25,420.10 crore, up 15.58% year on year, and net profit of Rs 2,002.70 crore, up 33.06%. Net profit has compounded at 16.13% a year since FY22, while revenue has grown 14.59% a year. Operating margin was 15.80% in FY26.
In the June 2026 quarter, revenue rose 20.57% to Rs 7,092.30 crore and net profit grew 38.41% to Rs 610.40 crore. The share price has gained 83.08% over five years. Domestic institutions raised their holding from 21.12% in September 2025 to 22.07% in September 2026. The stock trades at a PE of 56.64 against an industry PE of 60.75, below the sector average, with a return on equity of 20.48%.
Laurus Labs: Revenue Up 22.01% in FY26
Laurus Labs makes active pharmaceutical ingredients and formulations and offers contract development and manufacturing services. It reported FY26 revenue of Rs 6,867.85 crore, up 22.01% year on year, and net profit of Rs 889.85 crore, up 151.08%. Revenue has compounded at 8.53% a year since FY22. Operating margin was 26.90% in FY26. The debt-to-equity ratio is 0.48.
The stock trades at a PE of 108.57 against an industry PE of 36.42, with a return on equity of 16.77%. In the June 2026 quarter, revenue rose 28.83% to Rs 2,035.49 crore and net profit grew 124.73% to Rs 361.99 crore. The share price has gained 221.40% over five years and 137.53% over the past year. Domestic institutions raised their holding from 11.94% in June 2025 to 13.74% in June 2026.
Fund Backed Fast Profit Growth Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these fund backed fast profit growth stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| M&M | 2,02,084.34 | 18,621.71 | 25.21% | 22.04% | 26.58% | 20.77% |
| CG Power | 12,662.22 | 1,196.73 | 25.73% | 23.06% | 17.42% | 14.66% |
| Apollo Hospitals | 25,420.10 | 2,002.70 | 15.58% | 14.59% | 16.13% | 16.39% |
| Laurus Labs | 6,867.85 | 889.85 | 22.01% | 8.53% | 1.68% | 31.95% |
Check the Univest Screener for live data on these fund backed fast profit growth stocks
Institutional Holding in M&M, CG Power, Apollo Hospitals and Laurus Labs
Institutional holding shows who is backing these fund backed fast profit growth stocks alongside the promoter. The table uses the latest reported quarter for each. M&M has the deepest institutional backing, with FII and DII together holding 67.54% as of June 2026. Domestic institutions increased their holding over the past year in M&M (from 29.59% to 32.65%), CG Power (from 16.33% to 18.30%), Apollo Hospitals (from 21.12% to 22.07%) and Laurus Labs (from 11.94% to 13.74%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| M&M | 18.45% | 34.89% | 32.65% | 14.01% | June 2026 |
| CG Power | 56.36% | 11.97% | 18.30% | 13.37% | June 2026 |
| Apollo Hospitals | 28.02% | 43.18% | 22.07% | 6.72% | September 2026 |
| Laurus Labs | 27.47% | 28.00% | 13.74% | 30.78% | June 2026 |
Risks to Weigh in Fund Backed Fast Profit Growth Stocks
Being careful with fund backed fast profit growth stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Laurus Labs trades at a PE of 108.57 against an industry PE of 36.42, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Fund Backed Fast Profit Growth Stocks
Picking from fund backed fast profit growth stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (23.82 to 60.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track M&M, CG Power, Apollo Hospitals and Laurus Labs live prices.
Conclusion
Among fund backed fast profit growth stocks, M&M stands out for the fastest profit growth, 26.58% a year since FY22, CG Power for the biggest five-year price gain at 563.19%, Apollo Hospitals for the highest return on equity at 20.48% and Laurus Labs for the strongest latest-quarter profit growth at 124.73%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing fund backed fast profit growth stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Fund Backed Fast Profit Growth Stocks to Watch
Which are the best fund backed fast profit growth stocks to watch for multibagger potential?
Ans. M&M, CG Power, Apollo Hospitals and Laurus Labs are the 4 names this list highlights, with market caps of Rs 3,51,212 crore, Rs 1,30,876 crore, Rs 1,23,036 crore and Rs 1,18,375 crore respectively. M&M is notable for the fastest profit growth, 26.58% a year since FY22. CG Power stands out for the biggest five-year price gain at 563.19%. Apollo Hospitals offers the highest return on equity at 20.48%. Laurus Labs brings the strongest latest-quarter profit growth at 124.73%. These are watchlist names for fund backed fast profit growth stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Apollo Hospitals a good stock for long-term investors?
Ans. Apollo Hospitals has a return on equity of 20.48%, a PE of 56.64 against an industry PE of 60.75 and a market cap of Rs 1,23,036 crore. Net profit has compounded at 16.13% a year since FY22, and FY26 revenue rose 15.58% while June 2026 quarter net profit grew 38.41%. Long-term returns in fund backed fast profit growth stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can M&M become a multibagger from here?
Ans. M&M has already gained 220.52% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in fund backed fast profit growth stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 26.58% a year since FY22, and FY26 revenue rose 25.21%. At a PE of 17.35 against an industry PE of 23.82, valuation should be checked against that growth before investing.
What is the market cap of M&M, CG Power, Apollo Hospitals and Laurus Labs?
Ans. As of 29 October 2026, M&M has a market cap of Rs 3,51,212 crore, CG Power has a market cap of Rs 1,30,876 crore, Apollo Hospitals has a market cap of Rs 1,23,036 crore and Laurus Labs has a market cap of Rs 1,18,375 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on fund backed fast profit growth stocks.
What are the risks of investing in fund backed fast profit growth stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Laurus Labs trades at a PE of 108.57 against an industry PE of 36.42, so earnings growth needs to hold up.
Why is Laurus Labs trading at a PE of 108.57?
Ans. Laurus Labs’ PE of 108.57 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.77%, latest-quarter profit growth of 124.73% and FY26 revenue growth of 22.01%, which also means the stock is more sensitive if growth slows. Investors in fund backed fast profit growth stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in M&M, CG Power, Apollo Hospitals and Laurus Labs?
Ans. As of the latest reported quarter, FII and DII together hold 67.54% of M&M (34.89% and 32.65%), 30.27% of CG Power (11.97% and 18.30%), 65.25% of Apollo Hospitals (43.18% and 22.07%) and 41.74% of Laurus Labs (28.00% and 13.74%). Rising institutional holding is a useful signal in fund backed fast profit growth stocks, though it should be read with earnings trends rather than on its own.
